MYC and COVID-19: In accordance with the PPI analyses, we found that the V-ATPase subunit ATP6V1B2, the c-MYC co-activator TRRAP, and the cohesin complex subunit SMC3 were associated with the COVID-19 patient hospitalization, suggesting their clinical relevance to disease.